14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $355.79 $421.00 Wednesday, 1st May 2024 MEDP stock ended at $397.86. This is 2.45% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 4.45% from a day low at $386.42 to a day high of $403.62.
90 days $286.76 $421.00
52 weeks $197.39 $421.00

Historical Medpace Holdings Inc prices

Date Open High Low Close Volume
May 01, 2024 $386.77 $403.62 $386.42 $397.86 280 957
Apr 30, 2024 $399.27 $400.95 $386.73 $388.35 220 044
Apr 29, 2024 $397.53 $403.27 $397.21 $400.21 192 294
Apr 26, 2024 $391.72 $397.17 $388.88 $395.93 143 006
Apr 25, 2024 $394.47 $394.47 $379.73 $389.77 310 234
Apr 24, 2024 $415.00 $421.00 $394.00 $397.56 417 769
Apr 23, 2024 $378.00 $414.61 $355.79 $407.15 779 385
Apr 22, 2024 $374.65 $381.79 $370.85 $376.26 349 785
Apr 19, 2024 $375.50 $377.86 $368.37 $372.00 211 679
Apr 18, 2024 $381.04 $386.24 $373.99 $374.32 219 879
Apr 17, 2024 $387.64 $389.27 $381.25 $382.44 204 080
Apr 16, 2024 $389.59 $390.50 $384.70 $385.05 307 749
Apr 15, 2024 $399.19 $399.62 $387.13 $387.14 137 835
Apr 12, 2024 $398.74 $398.88 $392.71 $395.00 133 728
Apr 11, 2024 $401.25 $404.39 $394.57 $402.30 129 862
Apr 10, 2024 $395.01 $401.18 $392.01 $397.72 151 914
Apr 09, 2024 $412.15 $412.25 $400.99 $404.77 120 630
Apr 08, 2024 $400.46 $409.31 $397.30 $408.71 314 680
Apr 05, 2024 $386.06 $403.96 $386.06 $400.75 174 229
Apr 04, 2024 $400.41 $400.69 $388.55 $389.20 142 982
Apr 03, 2024 $389.29 $396.60 $387.75 $396.12 181 844
Apr 02, 2024 $395.00 $395.00 $386.78 $392.51 212 747
Apr 01, 2024 $405.00 $406.58 $397.45 $397.99 171 846
Mar 28, 2024 $403.42 $407.14 $401.76 $404.15 169 537
Mar 27, 2024 $406.85 $409.43 $398.79 $403.27 101 926
Click to get the best stock tips daily for free!

About Medpace Holdings Inc

Medpace Holdings Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory... MEDP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT